Positron emission tomography scan for predicting clinical outcome of patients with recurrent cervical carcinoma following radiation therapy

Journal of Cancer Research and Therapeutics

Volumn 8, Issue 1, 2012, Pages 23-27

  Sharma, Daya Nand ^a   Rath, Goura Kisor ^a   Kumar, Rakesh ^a   Malhotra, Arun ^a   Kumar, Sunesh ^a   Pandjatcharam, Jagadesan ^a   Maharjan, Sagar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cervical carcinoma; positron emission tomography scan; predictive value; recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; POSITRON EMISSION TOMOGRAPHY; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RECURRENT CANCER; SALVAGE THERAPY; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 84860452574     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.95169     Document Type: Article

References (25)

1. Perez CA, Camel HM, Kuske RR, Kao MS, Galakatos A, Hederman MA, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: A 20-year experience. Gynecol Oncol 1986;23:127-40. (Pubitemid 16155028)
2. Ferrigno R, Campos de Oliveira Faria SL, Weltman E, Salvajoli JV, Segreto RA, Pastore A, et al. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: Retrospective analysis of results and variables. Int J Radiat Oncol Biol Phys 2003;55:695-706. (Pubitemid 36172490)
3. Waggoner SE. Cervical cancer. Lancet 2003;361:2217-25. (Pubitemid 36782559)
4. Sommers GM, Grigsby PW, Perez CA, Camel HM, Kao MS, Galakatos AE, et al. Outcome of recurrent cervical carcinoma following definitive irradiation. Gynecol Oncol 1989;35:150-5. (Pubitemid 19268547)
5. Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, et al. Recurrent squamous cell carcinoma of cervix following definitive radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:249-57.
6. Friedlander M, Grogan M; U.S. Preventative Services Task Force. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist 2002;7:342-7. (Pubitemid 34919958)
7. Randall ME, Evans L, Greven KM, McCunniff AJ, Doline RM. Interstitial reirradiation for recurrent gynecologic malignancies: Results and analysis of prognostic factors. Gynecol Oncol 1993;48:23-31. (Pubitemid 23056182)
8. Chiva LM, Lapuente F, González-Cortijo L, González- Martín A, Rojo A, García JF, et al. Surgical treatment of recurrent cervical cancer: State of the art and new achievements. Gynecol Oncol 2008;110 (3 Suppl 2):S60-6.
9. Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM Jr. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989;73:1027-34. (Pubitemid 19143843)
10. Yen TC, Lai CH. Positron emission tomography in gynecologic cancer. Semin Nucl Med 2006;36:93-104.
11. Wright JD, Dehdashti F, Herzog TJ, Mutch DG, Huettner PC, Rader JS, et al. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer 2005;104:2484-91. (Pubitemid 41691572)
12. Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 2002;53:353-9. (Pubitemid 34522101)
13. Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I. Post therapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome. J Clin Oncol 2004;22:2167-71. (Pubitemid 41095151)
14. Xue F, Lin LL, Dehdashti F, Miller TR, Seigel BA, Grigsby PW. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol 2006;101:147-51.
15. Lin LL, Yang Z, Mutic S, Miller TR, Grigsby PW. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. Int J Radiat Oncol Biol Phys 2006;65:177-81.
16. Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 Fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 2007;110:1738-44. (Pubitemid 47557298)
17. Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Detection of early recurrence with FDG-PET in patients with cervical cancer. J Nucl Med 2003;44:347-52.
18. Lai CH, Huang KG, See LC, Yen TC, Tsai CS, Chang TC, et al. Restaging of recurrent cervical carcinoma with dual-phase [18F] fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 2004;100:544-52.
19. Sakurai H, Suzuki Y, Nonaka T, Ishikawa H, Shioya M, Kiyohara H, et al. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy -tumor volume and FDG uptake value. Gynecol Oncol 2006;100:601-7. (Pubitemid 43246878)
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Assoc 1958;53:457-81.
21. National Medical Registry Programme. Population based cancer registry, Delhi, 2001-2003. New Delhi, India: Indian council of medical research.
22. Rath GK, Mohanti BK. Textbook of radiation oncology -Principles and Practice. New Delhi: B.I. Churchil Livingstones; 2000.
23. Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, et al. The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results. Gynecol Oncol 2009;115:65-8.
24. Constine LS, Milano MT, Friedman D, Morris M, Williams JP, Rubin P, et al. Late effects of cancer treatment on normal tissues. In: Halperin EC, Parez CA, Brady LW. Perez and Brady's Principles and Practice of Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2008. p. 320.
25. Lin CT, Yen TC, Chang TC, Ng KK, Tsai CS, Ho KC, et al. Role of [18F] fluoro-2-deoxy-D-glucose positron emission tomography in rerecurrent cervical cancer. Int J Gynecol Cancer 2006;16:1994-2003.